Effects of levosimendan on cardiac arrhythmia: electrophysiologic and ambulatory electrocardiographic findings in phase II and phase III clinical studies in cardiac failure
- 1 June 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (12) , 16-20
- https://doi.org/10.1016/s0002-9149(99)00313-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Electrophysiologic and proarrhythmic effects of intravenous inotropic agentsProgress in Cardiovascular Diseases, 1995
- Hemodynamic and neurohumoral effects of levosimedan, a new calcium sensitizer, at rest and during exercise in healthy menThe American Journal of Cardiology, 1995
- Dose-Range Study of a New Calcium Sensitizer, Levosimendan, in Patients with Left Ventricular DysfunctionJournal of Cardiovascular Pharmacology, 1995
- Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failureJournal of the American College of Cardiology, 1993
- Effect of milrinone on ventricular arrhythmias in congestive heart failureThe American Journal of Cardiology, 1990
- Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1987
- Application of a frequency definition of ventricular proarrhythmiaThe American Journal of Cardiology, 1987
- Electrophysiologic effects of milrinone in patients with congestive heart failureThe American Journal of Cardiology, 1986
- Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinoneAmerican Heart Journal, 1986
- Milrinone in congestive heart failure: Observations on ambulatory ventricular arrhythmiasAmerican Heart Journal, 1985